News
Filing of market authorization approval
22/02/01

SUSMED has successfully filed market authorization approval about DTx for Insomnia.

Previous
Back to list
Next
Latest Article
2025/11/06
FISCO Analyst Report
2025/10/16
Presentation at the 70th Congress of Japan Audiological Society about our DTx
2025/01/28
ASKA and SUSMED Starts Specified Clinical Trial Using Digital Therapeutics App Designed for Patients with PMS/PMDD